COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B - 1st Edition - ISBN: 9780128241431, 9780128241448

Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B, Volume 177

1st Edition

Serial Editor: David Teplow
Hardcover ISBN: 9780128241431
eBook ISBN: 9780128241448
Imprint: Academic Press
Published Date: 16th January 2021
Page Count: 220
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents


David Teplow 


1. Relevance of transgenic mouse models for Alzheimer's disease 

Leon Tai, Juan Maldonado Weng, Mary Jo LaDu and Scott Brady 


2. Mitochondrial transplant to replenish damaged mitochondria: A novel therapeutic strategy for neurodegenerative diseases?

Abhisek Mukherjee, Andrea D Becerra Calixto, Melissa Chavez, Jean Paul Delgado Charris and Claudio Soto 


3. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy 

Yanina Ivashko-Pachima and Illana Gozes 


4. Applying available knowledge and resources to alleviate familial and sporadic neurodegenerative disorders 

Mark P. Mattson 


5. The cellular machinery of post-endocytic APP trafficking in Alzheimer's disease: A future target for therapeutic intervention? 

Lawrence S.B. Goldstein and Utpal Das 


6. The search for novel targets in Alzheimer's disease—The 90s redux 

Christian Behl 


7. Adult hippocampal neurogenesis in Alzheimer's disease 

Ahmed Disouky and Orly Lazarov 


8. Early detection and personalized medicine: Future strategies against Alzheimer's disease 

Antonio Di Meco and Robert Vassar 


9. Inflammation and Parkinson’s disease pathogenesis: Mechanisms and therapeutic insight 

Gianluigi Forloni, Pietro la Vitola, Milica Cerovic and Claudia Balducci 


Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part B, Volume 177 in the Progress in Molecular Biology and Translational Science series, provides the most topical, informative and exciting monographs available on a wide variety of research topics. The series includes in-depth knowledge on the molecular biological aspects of organismal physiology, with this release including chapters on Alzheimer's disease, Prion-like propagation of alpha-synuclein, What - if anything - can we learn about neurodegenerative diseases from yeast?, Mitochondrial rejuvenation and replacement as a novel strategy for treatment of age-related neurodegenerative diseases, and more.

Key Features

  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field


Scientists working actively in a field, including those at levels ranging from graduate student to senior investigator. New investigators to a field who wish to familiarize themselves with the latest work


No. of pages:
© Academic Press 2021
16th January 2021
Academic Press
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Serial Editor

David Teplow

David Teplow

Professor Teplow is a member of the Department of Neurology, David Geffen School of Medicine at UCLA; Director, UCLA Biopolymer Laboratory; and a member of the faculties of the Molecular Biology Institute, Brain Research Institute, Chemistry-Biology Interface Training Program, and various neuroscience graduate programs. Professor Teplow received degrees in Biochemistry, and in Bacteriology & Immunology, from UC Berkeley; a Ph.D. from the University of Washington, Seattle; and postdoctoral training at the California Institute of Technology, Pasadena, CA. From 1991-2005, Professor Teplow was a member of the faculty of the Department of Neurology, Harvard Medical School, Boston. Professor Teplow has published >200 peer-reviewed articles, including ~150 original articles and ~50 reviews, book chapters, and commentaries. Professor Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology. He currently is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease. Professor Teplow is a member of numerous national and international scientific advisory and editorial boards.

Affiliations and Expertise

David Geffen School of Medicine, UCLA, Los Angeles, CA, USA